Rocuronium: Rocuronium will be administered intravenously as bolus and continuous infusion to achieve target neuromuscular blockade depth according to group allocation. Neuromuscular function will be monitored using quantitative TOF monitoring.
Study summary
This randomized controlled study aims to evaluate the effects of deep versus moderate neuromuscular blockade on intraoperative driving pressure and the development of postoperative critical respiratory events in patients undergoing abdominal surgery under general anesthesia.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Elective abdominal surgery under general anesthesia that is expected to last longer than one hour
* ASA I-II-III
* Age ≥18 years
* Written informed consent
Exclusion Criteria:
* Refusal to participate in the study
* ASA ≥ IV
* Age \<18
* Obesity (BMI\>30) and cachexia (BMI \<18)
* Laparoscopic surgery
* Emergency procedure
* Allergy to drugs used during induction and maintenance of general anesthesia
* Presence of psychiatric/neurologic/neuromuscular disease
* Risk of malignant hyperthermia or having any relative with history of malignant hyperthermia
* Use of medications that may affect neuromuscular function (anticonvulsants, aminoglycosides, magnesium salts, etc.)
* Pregnancy
* Presence of advanced chronic lung disease (asthma, COPD, etc.)
* Presence of advanced liver and renal disease (creatinine\>1.6, liver function tests above twice the normal range)
Primary outcome measure(s)
Mean Intraoperative Driving Pressure — From immediately after intubation until the end of surgery (intraoperative period) Driving pressure will be calculated as plateau pressure minus positive end-expiratory pressure (PEEP) during volume-controlled ventilation. Measurements will be recorded at 30-minute intervals throughout surgery, and the mean value per patient will be calculated.
Trial sites (1)
Facility
City
Region
Status
Ankara Bilkent City Hospital
Ankara
Çankaya
More Ankara City Hospital Bilkent trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.